← Leaderboards
Katelyn Mullen
Sloan-Kettering Inst Can Research
$140,482
Attributed
$140,482
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$140,482 · 1
By mechanism
F31$140,482 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Timothy An-Thy Chan$21,076,830
- Nikolaus Schultz$13,183,744
- Scott W Lowe$63,222,126
- Sohrab P Shah$4,881,319
- Eileen Mary O'Reilly$2,300,843
Others in their field
Other Emerging Leaders on “Aftercare”
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,888,963
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$13,559,983
- Ki Young Chung · Prisma Health - Upstate$8,495,983
- Deanna A Kulpa · Emory University$8,444,989
Research focus
AftercareComputing MethodologiesArchitectureBiologyBiopsyArid1a GeneCancer EtiologyCancer PatientCancer TypeCarcinogenesisCdkn2a GeneCellsCessation Of LifeBrca2 GeneChromatin ModificationChronologyClear Cell Renal Cell CarcinomaClinical Course Of DiseaseClinical DiagnosisClinical TrialsCodeCohortComplexDesmoplastic
Grant awards (3)
Genetic Determinants of Evolutionary Trajectories and Clinical Course in Pancreatic Cancer$47,694
F31 · FY2023 · CA · contact PI
Genetic Determinants of Evolutionary Trajectories and Clinical Course in Pancreatic Cancer$46,752
F31 · FY2022 · CA · contact PI
Genetic Determinants of Evolutionary Trajectories and Clinical Course in Pancreatic Cancer$46,036
F31 · FY2021 · CA · contact PI